Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Onychomycosis Among Cancer Patients Undergoing Chemotherapy in Tehran, Iran: A Cross-Sectional Study Publisher



Fathi F1 ; Shahi F2 ; Khosravi A3 ; Saffarian Z1 ; Safarian N4 ; Yekaninejad MS5 ; Shaka Z6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Breast Disease Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Microbiology and Immunology, School of Veterinary Medicine, Tehran University, Tehran, Iran
  4. 4. Haemostasis and Thrombosis Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Epidemiology, School of Public Heath, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Cancer Research Center, Cancer Institute, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Microbiology Published:2025


Abstract

Background and Objectives: Due to the persistence of residual fungal elements, onychomycosis tends to have a high recurrence rate. It is essential to determine the etiology and frequency of onychomycosis across various factors. This study aimed to assess the prevalence of onychomycosis and identify its fungal agents in cancer patients undergoing chemotherapy. Materials and Methods: This cross-sectional study was conducted on cancer patients attending the Oncology Clinic and Cancer Institute of Tehran University of Medical Sciences. Among the 165 patients meeting the inclusion criteria, 75 individuals with nail alterations were referred to a dermatologist. Each patient's information, including demographics, disease-related data, and details about nail involvement, was recorded. When onychomycosis was suspected, nail samples were collected from the deepest part and examined using a light microscope after clarifying with 15% potassium hydroxide (KOH) to detect fungal elements. Results: The prevalence of onychomycosis was 37.6% (n=62). Among the 75 patients with nail alterations and suspected onychomycosis, 17.3% (n=13) tested negative for pathogenic agents. The most common pathogen was Candida albicans, present in 21% (13/62) of patients with positive onychomycosis. The prevailing nail alteration was onycholysis, affecting 45.3% (34/75) of patients. Conclusion: Onychomycosis exhibits associations with variables such as gender, age, cancer and chemotherapy. © 2025 The Authors. Published by Tehran University of Medical Sciences.
Related Docs
1. High Incidence of Onychomycosis Due to Saprophytic Fungi in Yazd, Iran, Iranian Journal of Dermatology (2017)
2. A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination in Vitro Susceptibilities of Isolated Fungal Strains to Conventional and New Antifungals, Frontiers in Cellular and Infection Microbiology (2021)
3. Onychomycosis Due to Dermatophytes Species in Iran: Prevalence Rates, Causative Agents, Predisposing Factors and Diagnosis Based on Microscopic Morphometric Findings, Journal de Mycologie Medicale (2018)
4. Photodynamic Therapy-Mediated Extirpation of Cutaneous-Resistant Dermatophytosis With Ag@Zno Nanoparticles: An Efficient Therapeutic Approach for Onychomycosis, Nanomedicine (2022)
5. Aspergillus Species As Emerging Causative Agents of Onychomycosis, Journal de Mycologie Medicale (2015)
6. A Systematic Review and Meta-Analysis on the Epidemiology, Casual Agents and Demographic Characteristics of Onychomycosis in Iran, Journal de Mycologie Medicale (2019)
Experts (# of related papers)
View all Related Experts
Seyed Jamal Hashemi Hezaveh (4)
Roshanak Daei Ghazvini (2)